Abingworth LLP 13D/13G Filings for Vera Therapeutics, Inc. (VERA)

Abingworth LLP 13D and 13G filings for Vera Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-04-07
4:39 pm
Purchase		 2022-03-28 13D Vera Therapeutics, Inc.
VERA		 Abingworth LLP 2,970,156
11.100%		 9,925increase
(+0.34%)		 Filing
2021-05-24
09:34 am
Purchase		 2021-05-18 13D Vera Therapeutics, Inc.
VERA		 Abingworth LLP 2,960,231
14.600%		 2,960,231increase
(New Position)		 Filing